Since 2001, this training activity has been highly appreciated by participants and hosting departments. Each grant is amounting to € 1,500.- plus travel expenses of up to € 300.-. The purpose of this award is to support the accommodation and board expenses in the city of practice. The grant is supposed to allow a visit of a six weeks duration. If a participant is able to accept a low budget board, it may be possible to stay longer than six weeks in the hosting department.
-
-
Report from Dr Pawel Chochol from Poland visiting the Department of Neurology at the Royal London Hospital, United Kingdom under the supervision of Dr Salek-Haddadi. I visited the United Kingdom on an eight-week Department-Department Co-Operation Programme at the Royal London… Continue Reading
-
I would like to express my gratitude towards the European Academy of Neurology for the honour to organize the Regional Teaching Course in Sofia, Bulgaria which proved to be an event excelling in terms of attendance and content. In this respect I would like to thank all the invited speakers for their great responsiveness and support.
-
by Gian Luigi Lenzi Neuropenews has recently received the request to publish in the „Interviews“ section an interview where an eminent neurologist A was interviewing a second eminent neurologist B who had been awarded a prize in the country of… Continue Reading
-
Richard Frackowiak is head of the department of clinical neurosciences at the University of Lausanne, Switzerland, and co-director of the Human Brain Project. He is also chairman of the Medical Science Committee of Science Europe.
-
Gian Luigi Lenzi (GLL): As Chair of the Scientific Committee, can you illustrate the role you give to the EAN within the community of European neurologists?
Antonio Federico (AF): EAN has a very important role, because it is the only… Continue Reading -
Franz Gerstenbrand is 90 years!
-
The European Academy of Neurology has existed for 4 months now and many of the first steps are behind us. The latest step is that we can accept members now from the administrative side of the process. Therefore I will use my President’s Page today to explain why you should become a member. According to the bylaws of the Society we will have institutional and individual members.
-
Registration and abstract submission and registration are open now. Information on registration fees, etc. can be found here: http://www.eaneurology.org/berlin2015/Register.1884.0.html The guidelines for abstract submission, deadlines, etc. here: http://www.eaneurology.org/berlin2015/Call-for-Abstracts.2198.0.html Please log in to the registered user area on www.eaneurology.org/berlin2015 with your… Continue Reading
-
European Academy of Neurology ADMIN was re-audited and has received the updated certificate.
-
The October issue of the European Journal of Neurology is online now! Online access is free-of-charge for EAN members. Please contact headoffice@eaneurology.org, if you Need help with your access token. European Journal of Neurology was last modified: July 5th, 2016… Continue Reading
-
Gian Luigi Lenzi (GLL): As Secretary General to EAN, can you illustrate the role you give to EAN within the community of European Neurologists?
Didier Leys (DL): The EAN is a society of both individual members and national societies. This… Continue Reading -
The EAN is a young Society and our purpose is to promote ‘Excellence in Neurology in Europe’. This task has many facets and one of them is to engage more people in the Society. This process is presently underway.
-
Report from Dr. Naida Nasrullayeva from Azerbaijan visiting the Department of Neurology at the University Hospital Copenhagen, Denmark under the supervision of Doctor Michael Oettinger. First of all, I would like to thank EFNS (EAN) for the opportunity to visit… Continue Reading
-
Rudolf Martini, Würzburg, Germany, was the first speaker of this session and talked about opportunities for treatment of CMT diseases. At the moment, there is no cure for these genetic neuropathies. Studies (mouse and human) with many substances studied, such as ascorbic acid, progesterone antagonist, curcumin, neurotrophin 3, carried out without success.